• Avidity Biosciences (NASDAQ:RNA) Earns Buy Rating from Chardan Capital

    Источник: Buzz FX / 18 мар 2025 09:31:16   America/Chicago


    Avidity Biosciences (NASDAQ:RNA) Earns Buy Rating from Chardan Capital Written by MarketBeat March 18, 2025 Share Link copied to clipboard. Remove Ads Avidity Biosciences ( NASDAQ:RNA - Get Free Report ) 's stock had its "buy" rating reaffi
    Read more...
Опубликовать